Difference between revisions of "Part:BBa K2933170"
(5 intermediate revisions by one other user not shown) | |||
Line 19: | Line 19: | ||
<!-- --> | <!-- --> | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | <br> | + | This composite part is made up with six basic parts(Tac promoter,RBS a , Linker g, GST, Linker e and GIM-2). It encodes a protein which is GIM-2 fused with GST tag. The fusion protein is about 53.4 kD. In order to gain the highly purified target protein, we add GST tag in N-terminal of GIM-2 and combine the two parts with the cutting site of Prescission Protease. The fusion protein can be cut off at the cutting site by Prescission Protease. It is convenient for us to purify our target protein.<br> |
===Molecular cloning=== | ===Molecular cloning=== | ||
+ | First, we used the vector pGEX-6p to construct our expression plasmid. And then we converted the plasmid constructed to ''E. coli'' DH5α to expand the plasmid largely.<br> | ||
+ | |||
<p style="text-align: center;"> | <p style="text-align: center;"> | ||
[[File:GIM-2-PCR.jpeg|400px|]] [[File:GIM-2-veri.jpeg|250px|]]<br> | [[File:GIM-2-PCR.jpeg|400px|]] [[File:GIM-2-veri.jpeg|250px|]]<br> | ||
Line 29: | Line 31: | ||
− | ==References== | + | ===References=== |
1. Skagseth S , Akhter S , Paulsen M H , et al. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding[J]. European Journal of Medicinal Chemistry, 2017, 135:159-173. | 1. Skagseth S , Akhter S , Paulsen M H , et al. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding[J]. European Journal of Medicinal Chemistry, 2017, 135:159-173. | ||
Latest revision as of 02:01, 26 September 2019
Tac promoter+RBS a+Linker g+GST+Linker e+GIM-2
This part consists of Tac promoter,RBS and protein coding sequence (GST+Linker e+GIM-2),and the biological module can be built into E.coli for protein expression.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 1525
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 1525
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 1525
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 1525
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 181
Usage and Biology
This composite part is made up with six basic parts(Tac promoter,RBS a , Linker g, GST, Linker e and GIM-2). It encodes a protein which is GIM-2 fused with GST tag. The fusion protein is about 53.4 kD. In order to gain the highly purified target protein, we add GST tag in N-terminal of GIM-2 and combine the two parts with the cutting site of Prescission Protease. The fusion protein can be cut off at the cutting site by Prescission Protease. It is convenient for us to purify our target protein.
Molecular cloning
First, we used the vector pGEX-6p to construct our expression plasmid. And then we converted the plasmid constructed to E. coli DH5α to expand the plasmid largely.
Figure 1. Left: The result of PCR, Right:The result of double enzyme digestion verification
References
1. Skagseth S , Akhter S , Paulsen M H , et al. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding[J]. European Journal of Medicinal Chemistry, 2017, 135:159-173.
2. Wendel AF, MacKenzie CR. 2015. Characterization of a novel metallo-lactamase variant, GIM-2, from a clinical isolate of Enterobacter cloacae in Germany. Antimicrob Agents Chemother 59:1824 –1825.
3. Borra P S , Samuelsen O , Spencer J , et al. Crystal Structures of Pseudomonas aeruginosa GIM-1: Active-Site Plasticity in Metallo-beta-Lactamases[J]. Antimicrobial Agents and Chemotherapy, 2013, 57(2):848-854.
4. Susann S, Trine J C, Gro Elin K B, James S, Ørjan S, Hanna-Kirsti S. L. Role of Residues W228 and Y233 in the Structure and Activity of Metallo-β-Lactamase GIM-1. Antimicrobial Agents and Chemotherapy Jan 2016, 60 (2) 990-1002